Showing results (471-480 of 538) with videos related to

Sort By:
Pageof 54
Journal of Clinical Pharmacology|June 14, 2021
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite AnalysisEric S Schwenk, Marc C Torjman, Ruin Moaddel, et al.
Cephalalgia : an International Journal of Headache|July 29, 2020
Non-invasive vagus nerve stimulation for primary headache: A clinical updateStephen D Silberstein, Hsiangkuo Yuan, Umer Najib, et al.
The Journal of Headache and Pain|September 27, 2017
Blocking CGRP in migraine patients - a review of pros and consMarie Deen, Edvige Correnti, Katharina Kamm, et al.
Cephalalgia : an International Journal of Headache|May 21, 2019
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine modelsKristian A Haanes, Alejandro Labastida-Ramírez, Frank W Blixt, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 26, 2016
Mapping the calcitonin receptor in human brain stemRebekah L Bower, Sajedeh Eftekhari, Henry J Waldvogel, et al.
Cephalalgia : an International Journal of Headache|March 25, 2022
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studiesHans Christoph Diener, Peter McAllister, Tim P Jürgens, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 11, 2016
Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic MigraineShannon W Clark, Chengyuan Wu, David W Boorman, et al.
Neurology|November 2, 2012
Migraine headache is present in the aura phase: a prospective studyJakob M Hansen, Richard B Lipton, David W Dodick, et al.
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
Pageof 54